161 related articles for article (PubMed ID: 33614822)
21. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
[TBL] [Abstract][Full Text] [Related]
22. Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids.
Marzano M; Bejoy J; Cheerathodi MR; Sun L; York SB; Zhao J; Kanekiyo T; Bu G; Meckes DG; Li Y
Cells; 2019 Aug; 8(9):. PubMed ID: 31466320
[TBL] [Abstract][Full Text] [Related]
23. Disruption of histamine/H
Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
[TBL] [Abstract][Full Text] [Related]
24. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
[TBL] [Abstract][Full Text] [Related]
25. Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair.
Li Y; Liu T; Van Halm-Lutterodt N; Chen J; Su Q; Hai Y
Stem Cell Res Ther; 2016 Feb; 7():31. PubMed ID: 26883322
[TBL] [Abstract][Full Text] [Related]
26. Maintenance of undifferentiated state of human induced pluripotent stem cells through cytoskeleton-driven force acting to secreted fibronectin on a dendrimer-immobilized surface.
Kim MH; Kino-oka M
J Biosci Bioeng; 2014 Dec; 118(6):716-22. PubMed ID: 24947748
[TBL] [Abstract][Full Text] [Related]
27. Human induced pluripotent stem cell formation and morphology prediction during reprogramming with time-lapse bright-field microscopy images using deep learning methods.
Chu SL; Sudo K; Yokota H; Abe K; Nakamura Y; Tsai MD
Comput Methods Programs Biomed; 2023 Feb; 229():107264. PubMed ID: 36473419
[TBL] [Abstract][Full Text] [Related]
28. Kinetic analysis of deviation from the undifferentiated state in colonies of human induced pluripotent stem cells on feeder layers.
Kim MH; Masuda E; Kino-oka M
Biotechnol Bioeng; 2014 Jun; 111(6):1128-38. PubMed ID: 24420640
[TBL] [Abstract][Full Text] [Related]
29. Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo.
Fu W; Wang SJ; Zhou GD; Liu W; Cao Y; Zhang WJ
Stem Cells Dev; 2012 Mar; 21(4):521-9. PubMed ID: 21631153
[TBL] [Abstract][Full Text] [Related]
30. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
[TBL] [Abstract][Full Text] [Related]
31. Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior.
Bobis-Wozowicz S; Kmiotek K; Sekula M; Kedracka-Krok S; Kamycka E; Adamiak M; Jankowska U; Madetko-Talowska A; Sarna M; Bik-Multanowski M; Kolcz J; Boruczkowski D; Madeja Z; Dawn B; Zuba-Surma EK
Stem Cells; 2015 Sep; 33(9):2748-61. PubMed ID: 26031404
[TBL] [Abstract][Full Text] [Related]
32. Intracerebral transplantation of HLA-homozygous human iPSC-derived neural precursors ameliorates the behavioural and pathological deficits in a rodent model of ischaemic stroke.
Noh JE; Oh SH; Lee S; Lee S; Kim YH; Park HJ; Ju JH; Kim HS; Huh JY; Song J
Cell Prolif; 2020 Sep; 53(9):e12884. PubMed ID: 32713053
[TBL] [Abstract][Full Text] [Related]
33. Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3.
Okada M; Tada Y; Seki T; Tohyama S; Fujita J; Suzuki T; Shimomura M; Ofuji K; Kishino Y; Nakajima K; Tanosaki S; Someya S; Kanazawa H; Senju S; Nakatsura T; Fukuda K
Biochem Biophys Res Commun; 2019 Apr; 511(3):711-717. PubMed ID: 30827508
[TBL] [Abstract][Full Text] [Related]
34. Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model.
Tamura T; Tahara T; Inoue M; Nanjo R; Onoe H; Yamamoto T; Kawamata S
Stem Cells Transl Med; 2024 Jun; 13(6):572-581. PubMed ID: 38554123
[TBL] [Abstract][Full Text] [Related]
35. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
36. Morphological Analysis of Live Undifferentiated Cells Derived from Induced Pluripotent Stem Cells.
Osawa Y; Miyamoto T; Ohno S; Ohno E
Stem Cells Dev; 2018 Jan; 27(1):1-9. PubMed ID: 28978257
[TBL] [Abstract][Full Text] [Related]
37. [Perspectives regarding the potential use of human induced pluripotent stem cells for the development of and research on medicinal products].
Hayakawa T; Mizuguchi H
Brain Nerve; 2012 Jan; 64(1):47-57. PubMed ID: 22223501
[TBL] [Abstract][Full Text] [Related]
38. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
[TBL] [Abstract][Full Text] [Related]
39. Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification.
Al-Akashi Z; Zujur D; Kamiya D; Kato T; Kondo T; Ikeya M
Front Cell Dev Biol; 2023; 11():1089945. PubMed ID: 36814599
[TBL] [Abstract][Full Text] [Related]
40. Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells.
Osada N; Kikuchi J; Umehara T; Sato S; Urabe M; Abe T; Hayashi N; Sugitani M; Hanazono Y; Furukawa Y
Oncotarget; 2018 Jan; 9(5):6450-6462. PubMed ID: 29464084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
